1 Min Read
Oct 12 (Reuters) - Cantargia AB :
* Opposition has been filed in europe against Cantargia’s patent regarding solid tumors Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.